Global Pneumococcal Vaccine Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Pneumococcal Vaccine market size will reach 8,193.28 Million USD in 2025 and is projected to reach 9,143.56 Million USD by 2032, with a CAGR of 1.58% (2025-2032). Notably, the China Pneumococcal Vaccine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The pneumococcal vaccine is a preventive immunization designed to protect against infections caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium is a major cause of serious respiratory illnesses, such as pneumonia, meningitis, and septicemia, particularly in young children, the elderly, and individuals with weakened immune systems. The pneumococcal vaccine stimulates the immune system to produce antibodies against specific strains of the bacterium, reducing the likelihood of infection and its potentially severe complications. There are different types of pneumococcal vaccines, including conjugate and polysaccharide vaccines, each targeting various age groups and offering protection against a range of pneumococcal strains. The vaccine is a vital component of routine immunization schedules globally, contributing significantly to the prevention of pneumococcal diseases and their associated morbidity and mortality.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur, CDIBP, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Pneumococcal Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pneumococcal Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Pneumococcal Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pneumococcal Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Pneumococcal Vaccine Include:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Pneumococcal Vaccine Product Segment Include:
PPSV 23
PCV 7/13
PCV 10
Pneumococcal Vaccine Product Application Include:
Child
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Pneumococcal Vaccine Industry PESTEL Analysis
Chapter 3: Global Pneumococcal Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Pneumococcal Vaccine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Pneumococcal Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Pneumococcal Vaccine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Pneumococcal Vaccine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Pneumococcal Vaccine market size will reach 8,193.28 Million USD in 2025 and is projected to reach 9,143.56 Million USD by 2032, with a CAGR of 1.58% (2025-2032). Notably, the China Pneumococcal Vaccine market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
The pneumococcal vaccine is a preventive immunization designed to protect against infections caused by the bacterium Streptococcus pneumoniae, also known as pneumococcus. This bacterium is a major cause of serious respiratory illnesses, such as pneumonia, meningitis, and septicemia, particularly in young children, the elderly, and individuals with weakened immune systems. The pneumococcal vaccine stimulates the immune system to produce antibodies against specific strains of the bacterium, reducing the likelihood of infection and its potentially severe complications. There are different types of pneumococcal vaccines, including conjugate and polysaccharide vaccines, each targeting various age groups and offering protection against a range of pneumococcal strains. The vaccine is a vital component of routine immunization schedules globally, contributing significantly to the prevention of pneumococcal diseases and their associated morbidity and mortality.
The major global manufacturers of Pneumococcal Vaccine include Pfizer, GSK, MSD, Sanofipasteur, CDIBP, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Pneumococcal Vaccine. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Pneumococcal Vaccine market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Pneumococcal Vaccine market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Pneumococcal Vaccine industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Pneumococcal Vaccine Include:
Pfizer
GSK
MSD
Sanofipasteur
CDIBP
Pneumococcal Vaccine Product Segment Include:
PPSV 23
PCV 7/13
PCV 10
Pneumococcal Vaccine Product Application Include:
Child
Adult
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Pneumococcal Vaccine Industry PESTEL Analysis
Chapter 3: Global Pneumococcal Vaccine Industry Porter's Five Forces Analysis
Chapter 4: Global Pneumococcal Vaccine Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Pneumococcal Vaccine Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Pneumococcal Vaccine Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Pneumococcal Vaccine Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Pneumococcal Vaccine Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Pneumococcal Vaccine Product by Type
- 1.2.1 PPSV 23
- 1.2.2 PCV 7/13
- 1.2.3 PCV 10
- 1.3 Pneumococcal Vaccine Product by Application
- 1.3.1 Child
- 1.3.2 Adult
- 1.4 Global Pneumococcal Vaccine Market Revenue and Sales Analysis
- 1.4.1 Global Pneumococcal Vaccine Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Pneumococcal Vaccine Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Pneumococcal Vaccine Market Sales Price Trend Analysis (2020-2032)
- 1.5 Pneumococcal Vaccine Market Development Status and Trends
- 1.5.1 Pneumococcal Vaccine Industry Development Status Analysis
- 1.5.2 Pneumococcal Vaccine Industry Development Trends Analysis
- 2 Pneumococcal Vaccine Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Pneumococcal Vaccine Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Pneumococcal Vaccine Market Analysis by Country
- 4.1 Global Pneumococcal Vaccine Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Pneumococcal Vaccine Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Pneumococcal Vaccine Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Pneumococcal Vaccine Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Pneumococcal Vaccine Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Pneumococcal Vaccine Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Pneumococcal Vaccine Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Pneumococcal Vaccine Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Pneumococcal Vaccine Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Pneumococcal Vaccine Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Pneumococcal Vaccine Average Sales Price by Manufacturers (2021-2025)
- 5.2 Pneumococcal Vaccine Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Pneumococcal Vaccine Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Pneumococcal Vaccine Market Analysis by Type
- 6.1 Global Pneumococcal Vaccine Market Revenue Analysis by Type
- 6.1.1 Global Pneumococcal Vaccine Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Pneumococcal Vaccine Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Pneumococcal Vaccine Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Pneumococcal Vaccine Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Pfizer
- 7.1.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Pfizer Pneumococcal Vaccine Product Portfolio
- 7.1.3 Pfizer Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 GSK
- 7.2.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 GSK Pneumococcal Vaccine Product Portfolio
- 7.2.3 GSK Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 MSD
- 7.3.1 MSD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 MSD Pneumococcal Vaccine Product Portfolio
- 7.3.3 MSD Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Sanofipasteur
- 7.4.1 Sanofipasteur Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Sanofipasteur Pneumococcal Vaccine Product Portfolio
- 7.4.3 Sanofipasteur Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 CDIBP
- 7.5.1 CDIBP Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 CDIBP Pneumococcal Vaccine Product Portfolio
- 7.5.3 CDIBP Pneumococcal Vaccine Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Pneumococcal Vaccine Industry Chain Analysis
- 8.2 Pneumococcal Vaccine Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Pneumococcal Vaccine Product Downstream Application Analysis
- 8.3.1 Global Pneumococcal Vaccine Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Pneumococcal Vaccine Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Pneumococcal Vaccine Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Pneumococcal Vaccine Typical Downstream Customers
- 8.5 Pneumococcal Vaccine Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
